Scientists are exploring a new way to harness the medical promise of psychedelic compounds without the mind-bending side effects. Researchers created modified versions of psilocin — the active form of ...
Psilocybin - the psychoactive compound in "magic mushrooms" - is gaining scientific attention for its potential in treating ...
Clinical trials are showing that DMT — the psychedelic compound in ayahuasca — can produce rapid antidepressant effects in a ...
A new study in Communications Biology provides evidence that a psychedelic drug induces a hybrid sleep-wake state in active mice. This unusual brain activity suggests a potential mechanism for how ...
Enveric Biosciences has presented research highlighting the its lead compound, EB-003 at the 7th Neuropsychiatric Drug Summit. EB-003 is a neuropathogenic and non-hallucinogenic N, ...
Tel Aviv, Israel, Feb. 22, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd. (SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat ...
Enveric receives its first patent for psychedelic-derived mescaline compounds. Non-hallucinogenic drugs aim to help with addiction, ADHD and anxiety. See what Wall Street is buying with instant access ...
Psilocybin, the best-known psychedelic substance derived from "magic" mushrooms, is a Schedule I substance: an illegal drug considered to have no medical use and high potential for abuse. So what’s in ...
Every mind-bending molecule in nature has an evolutionary origin; a defense against being eaten, a lure for pollinators, or perhaps a happy biochemical accident. Though they seem extraordinary, life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results